Durham gene editing firm raising $40M for Hepatitis B treatment

Precision BioSciences continues to push forward its gene editing platform even as a wave of challenges impacts the sector.

Source: bizjournals.com Health Care:Biotechnology headlines - March 4, 2024 Category: Biotechnology Authors: Zac Ezzone Source Type: news